Zobrazeno 1 - 10
of 29
pro vyhledávání: '"venous thrombotic event"'
Publikováno v:
Brazilian Neurosurgery, Vol 42, Iss 04, Pp e354-e357 (2023)
Since the COVID-19 pandemic started, millions of peoples are involved. The presentation of the disease varies from mild respiratory symptoms and multiple organ failure to coma and death. Neurological symptoms such as headache or seizure are also coin
Externí odkaz:
https://doaj.org/article/7c5cc75aaf9543c9978666cda84760db
Autor:
Brett Salomon, MD, Vinod Dasa, MD, Peter C. Krause, MD, Lauren Hall, PhD, Andrew G. Chapple, PhD
Publikováno v:
Arthroplasty Today, Vol 8, Iss , Pp 254-257.e1 (2021)
Background: The prevalence of venous thromboembolism (VTE) after total joint arthroplasty (TJA) is 0.40%-1.2%. Trends in TJA are for shorter hospital stays with lower complication rates. The aim of this study is to evaluate whether hospital length of
Externí odkaz:
https://doaj.org/article/3f859c8e130744a8a2d9550f8fd6c2dd
Autor:
Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 1361-1368 (2018)
Nobuhiro Kanaji,1 Hitoshi Mizoguchi,1 Takuya Inoue,1 Akira Tadokoro,2 Naoki Watanabe,1 Tomoya Ishii,1 Yasunori Tojo,2 Masahiro Yamaguchi,3 Norimitsu Kadowaki1 1Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medi
Externí odkaz:
https://doaj.org/article/5a067bfe2a204d13b13ec3a8106d8595
Publikováno v:
Journal of General Internal Medicine
Background Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. Objective To determine the admission pDd cut-off value associated with in-hospital VTE in patients with COV
Publikováno v:
Cureus
Background and objectives Cerebral venous sinus thrombosis (CVST) is a relatively rare and underdiagnosed type of stroke. Rivaroxaban is licensed for venous thromboembolism in patients opting for elective knee and hip replacement surgeries, preventin
Publikováno v:
Arthroplasty Today, Vol 8, Iss, Pp 254-257.e1 (2021)
Arthroplasty Today
Arthroplasty Today
Background: The prevalence of venous thromboembolism (VTE) after total joint arthroplasty (TJA) is 0.40%-1.2%. Trends in TJA are for shorter hospital stays with lower complication rates. The aim of this study is to evaluate whether hospital length of
Autor:
Vicente Giner-Galvañ, Jesús Javier González Igual, Luis Manzano, Anthony Gurjian Arena, Philip Erick Wikman-Jorgensen, Juan Santos, Santiago Jesús Freire Castro, Jeffrey Oskar Magallanes Gamboa, Manuel Méndez Bailón, Javier García Alegría, Ruth Calderón Hernaiz, Julio González Moraleja, Jaime Laureiro, Manuel Rubio-Rivas, Judit Aranda Lobo, María José García Blanco, Amara González Noya, Francisco Arnalich-Fernández, Ricardo Gómez Huelgas, José Luis Beato Pérez, Juan Antonio Vargas Núñez, Luis Arribas Pérez, Carlos Lumbreras Bermejo, Carles García-Cervera, Jesús Díez-Manglano
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
JOURNAL OF GENERAL INTERNAL MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
JOURNAL OF GENERAL INTERNAL MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
Background: Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. Objective: To determine the admission pDd cut-off value associated with in-hospital VTE in patients with C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a77e04125513b170f363f5c30b8889f
http://zaguan.unizar.es/record/110609
http://zaguan.unizar.es/record/110609
Autor:
Nathan D. Wong, Matthew J. Budoff, Keith Ferdinand, Ian M. Graham, Erin D. Michos, Tina Reddy, Michael D. Shapiro, Peter P. Toth
Publikováno v:
American Journal of Preventive Cardiology. 10:100335
Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity both in generally healthy persons and in those with known ASCVD. The foundation of preventive cardiology begins with assessing baseline ASCVD risk using global r
Autor:
Norimitsu Kadowaki, Masahiro Yamaguchi, Nobuhiro Kanaji, Akira Tadokoro, Yasunori Tojo, Hitoshi Mizoguchi, Takuya Inoue, Naoki Watanabe, Tomoya Ishii
Publikováno v:
Therapeutics and Clinical Risk Management
Nobuhiro Kanaji,1 Hitoshi Mizoguchi,1 Takuya Inoue,1 Akira Tadokoro,2 Naoki Watanabe,1 Tomoya Ishii,1 Yasunori Tojo,2 Masahiro Yamaguchi,3 Norimitsu Kadowaki1 1Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.